LicianPro

ALGS holders · CITADEL ADVISORS LLC 13F · ALGS stock

CITADEL ADVISORS LLC Aligos Therapeutics Inc (ALGS) 13F holding

CITADEL ADVISORS LLC reported 54,311 ALGS shares valued at $403.5K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest ALGS 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the ALGS holders table.

ALGS reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-3154,311$403.5KCOM NEW
2025-12-3151,834$483.1KCOM NEW
2025-09-3010,310$101.0KCOM NEW
2025-06-3015,198$109.6KCOM NEW

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.